指南与共识男科与性医学

睾酮缺乏评估与管理:AUA指南

Evaluation and Management of Testosterone Deficiency: AUA Guideline.
指南 / 共识 · J Urol · 2018-03-28

该AUA指南由多学科专家组制定,基于系统综述证据,为临床医生提供睾酮缺乏患者的评估与睾酮治疗管理的规范指导。指南强调准确评估总睾酮水平、症状与体征,并重视治疗监测,同时关注心血管疾病、前列腺癌风险及生育力保留等特殊人群。

要点

  • 评估应聚焦总睾酮水平、症状与体征的准确判断。
  • 治疗监测需确保睾酮水平达标并症状改善。
  • 需关注心血管病、前列腺癌风险及生育力保留人群。

核心结论

  • 睾酮缺乏患者的照护应聚焦于准确评估总睾酮水平、症状和体征,以及适当的治疗中监测以确保达到治疗性睾酮水平并改善症状。

研究设计与样本

  • 基于Mayo Clinic循证实践中心的系统综述及作者补充,由多学科专家组制定,证据陈述基于A、B或C级证据体强度,并指定为强、中、条件性推荐,另有临床原则或专家意见形式的陈述。

主要发现

  • 指南为临床医生提供了睾酮缺乏患者的正确评估及睾酮治疗安全有效管理的指导。
  • 额外陈述指导了有心血管疾病或前列腺癌风险或已患此类疾病患者以及有兴趣保留生育力患者的适当照护。

临床怎么用

  • 临床医生应准确评估总睾酮水平、症状与体征,并在治疗中监测以确保睾酮水平达标和症状改善。
  • 对心血管疾病或前列腺癌风险患者及希望保留生育力者,应按指南额外陈述进行适当照护。

局限性

  • 未来需要长期纵向观察研究和足够时长的临床试验来改进诊断技术和治疗,并提供更多关于睾酮治疗相关不良事件的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: There has been a marked increase in testosterone prescriptions in the past decade resulting in a growing need to give practicing clinicians proper guidance on the evaluation and management of the testosterone deficient patient. MATERIALS AND METHODS: A systematic review utilized research from the Mayo Clinic Evidence Based Practice Center and additional supplementation by the authors. Evidence-based statements were based on body of evidence strength Grade A, B, or C and were designated as Strong, Moderate, and Conditional Recommendations with additional statements presented in the form of Clinical Principles or Expert Opinions (table 1 in supplementary unabridged guideline, http://jurology.com/). RESULTS: This guideline was developed by a multi-disciplinary panel to inform clinicians on the proper assessment of patients with testosterone deficiency and the safe and effective management of men on testosterone therapy. Additional statements were developed to guide the clinician on the appropriate care of patients who are at risk for or have cardiovascular disease or prostate cancer as well as patients who are interested in preserving fertility. CONCLUSIONS: The care of testosterone deficient patients should focus on accurate assessment of total testosterone levels, symptoms, and signs as well as proper on-treatment monitoring to ensure therapeutic testosterone levels are reached and symptoms are ameliorated. Future longitudinal observational studies and clinical trials of significant duration in this space will improve diagnostic techniques and treatment of men with testosterone deficiency as well as provide more data on the adverse events that may be associated with testosterone therapy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018. PMID: 29601923. doi:10.1016/j.juro.2018.03.115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。